| Dec 15, 2021 |
Dec 17, 2021 |
Prelude Therapeutics Inc
|
EVP, Chief of Clinical Affairs |
Sell |
7.5
|
-28,751
|
-98.48%
|
✓
|
$373.8K |
| Nov 16, 2021 |
Nov 18, 2021 |
Prelude Therapeutics Inc
|
EVP, Chief of Clinical Affairs |
Sell |
7.5
|
-28,751
|
-98.48%
|
✓
|
$456.5K |
| Apr 29, 2021 |
Apr 30, 2021 |
Prelude Therapeutics Inc
|
EVP, Chief of Clinical Affairs |
Sell |
10.0
|
-3,223
|
-87.89%
|
✓
|
$129.9K |
| Apr 8, 2021 |
Apr 15, 2021 |
Prelude Therapeutics Inc
|
EVP, Chief of Clinical Affairs |
Sell |
25.0
|
-100
|
-18.38%
|
✓
|
$4K |
| Apr 7, 2021 |
Apr 9, 2021 |
Prelude Therapeutics Inc
|
EVP, Chief of Clinical Affairs |
Sell |
13.8
|
-1,000
|
-69.25%
|
✓
|
$40K |
| Sep 29, 2020 |
Sep 29, 2020 |
Prelude Therapeutics Inc
|
EVP, Chief of Clinical Affairs |
Buy |
90.0
|
+444
|
100.00%
|
✗
|
$8.4K |